Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
With respect to the prescription of semaglutide for ensuring weight management, Health Canada has given approval to the 2.4 mg of injection to serve as a measure to be implemented in addition to a reduced calorie diet and increased activity to manage weight in patients having: A BMI of 30 kg/m2 or higher (obesity) A BMI of 27 kg/m2 or higher (overweight) In addition to this, it is also expected that the patient should suffer from chronic weight-related issues, like dyslipidemia, hypertension, or obstructive sleep apnea
Meet the Experts Nayan Patel, MD, is an advanced biochemistry and anti-aging science expert and the founder of Auro Wellness, a skin-care company that focuses on antioxidants
There will be a temptation to want to give the oral dose right with a meal
These areas tend to have the biggest impact on maintaining daily stability while food intake is lower
If you meet the BMI criteria and have been unsuccessful with other weight management methods, your provider may recommend semaglutide as part of a well-structured plan
[18] Semaglutide (Wegovy) is now available through NHS specialist weight management services for adults with at least one weight-related comorbidity and a BMI of 35 kg/m or above (or 32.5 kg/m for certain ethnic groups), as recommended in NICE TA875
